Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001641172-25-021046
Filing Date
2025-07-25
Accepted
2025-07-25 17:09:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 form424b5.htm 424B5 545323
2 GRAPHIC form424b5_001.jpg GRAPHIC 3397
3 GRAPHIC form424b5_002.jpg GRAPHIC 4314
  Complete submission text file 0001641172-25-021046.txt   557425
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270684 | Film No.: 251152355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)